Institutional Review Board (IRB)

About the IRB

The Institutional Review Board (IRB) is committed to following the federal regulations to protect the rights and welfare of human subjects involved in research conducted under the auspices of the University of California, Riverside (UCR). UCR upholds the highest standards in the ethical conduct of research, including the protection of human participants, while enabling its faculty, staff and students to conduct research in a timely and efficient manner.

UCR currently has one IRB which functions as the review body for the approval and oversight of all human subjects research at UCR. The primary mission of the IRB is to facilitate those objectives by reviewing, approving, modifying or disapproving research applications submitted by UCR researchers, and in some cases, non-UCR researchers. The IRB process is based on rules and regulations for federally funded research, primarily the provisions of Protection of Human Subjects in the Code of Federal Regulations (45 CFR 46), and supporting materials such as the Belmont Report. UCR’s IRB strives to create an on-campus culture of respect for, and awareness of, the rights and welfare of human research participants, while advancing knowledge and facilitating the highest quality research.

Determine if you need to submit an IRB protocol

If your study meets the definition of human subjects research, you must submit an IRB protocol to the IRB Office. All human subjects research must receive prior approval from the IRB.

If you are unsure, you can complete and submit a Not Human Subjects Research (NHSR) Determination (formerly Determination of Activity or DOA) through the online IRB protocol submission system, Kuali. This submission type will assist the ORI in determining whether your activity meets the definition of ‘research involving human subjects' and requires IRB review/approval. For new submissions, please access UCR's Kuali Protocol Page.

Systematic Investigation	Attempts to answer research questions Is methodologically driven Data is analyzed in a disciplined way Conclusions are drawn from the results

Generalizable Knowledge	Activities are primarily designed to develop new knowledge or activities as part of a thesis, dissertation, coursework or degree requirements This can also include knowledge intended to be published or shared outside of the local context

Human Subject	Living individual(s) about whom an investigator conducting research: obtains information or biospecimens through intervention or interaction with the individual and uses, studies, or analyzes the information or biospecimens; or obtains, uses, studies, analyzes, or generates identifiable private information or identifiable biospecimens

Human Subjects Research	Requires prior review and approval by an IRB. Contact Research Compliance to ensure protection of your participants and also to adhere to Federal Regulations surrounding your research

Determine the Review Level

If your study needs IRB review, the next step is to identify the level of review required:

Full Board review
Expedited review
Exempt certification.

The level of review usually reflects the level of risk to the subject. The risk level is compared to "minimal risk" research as defined by federal regulations:

Definition of Minimal Risk

the probability and magnitude of harm or discomfort anticipated in the research are not greater than those ordinarily encountered in daily life or during the performance of routine physical or psychological examinations or tests [45, CFR 46, 102(j)].

The UCR Minimal Risk Tip Sheet is a tool developed by the ORC to help researchers determine what level of risk their studies may fall under. You can use this form to help you make this determination as part of your research on human subjects study application.

Full Board	IRB applications that involve more than minimal risk or do not meet the criteria for Exempt or Expedited. They are reviewed at a monthly convened IRB meeting. Examples of applications that may require full board review are studies using invasive procedures and research with investigational test articles.
Expedited	Minimal risk studies meeting specific criteria as outlined in 45 CFR 46.110. Applications are generally reviewed by a delegate process of IRB review.
Exempt	Revised Common Rule Studies originally approved on or after January 21, 2019, meeting specific criteria as outlined in 45 CFR 46.104(d) Exempt categories. Please note this excludes FDA regulated and DOJ funded studies. The IRB determines whether the claim for exemption is appropriate and whether it will be granted. Exemption from IRB review continues unless the application is to be modified such that it no longer will meet the criteria for exemption.	Common Rule Studies meeting specific criteria as outlined in 45 CFR 46.101(b). The IRB determines whether the claim for exemption is appropriate and whether it will be granted. Exemption from IRB review continues unless the application is to be modified such that it no longer will meet the criteria for exemption.

Full Board

IRB applications that involve more than minimal risk or do not meet the criteria for Exempt or Expedited. They are reviewed at a monthly convened IRB meeting. Examples of applications that may require full board review are studies using invasive procedures and research with investigational test articles.

Expedited

Minimal risk studies meeting specific criteria as outlined in 45 CFR 46.110. Applications are generally reviewed by a delegate process of IRB review.

Exempt

Revised Common Rule

Studies originally approved on or after January 21, 2019, meeting specific criteria as outlined in 45 CFR 46.104(d) Exempt categories. Please note this excludes FDA regulated and DOJ funded studies.
The IRB determines whether the claim for exemption is appropriate and whether it will be granted.
Exemption from IRB review continues unless the application is to be modified such that it no longer will meet the criteria for exemption.

Common Rule

Studies meeting specific criteria as outlined in 45 CFR 46.101(b).
The IRB determines whether the claim for exemption is appropriate and whether it will be granted. Exemption from IRB review continues unless the application is to be modified such that it no longer will meet the criteria for exemption.

Funding agencies do not allow investigators to make Exempt determinations on their own, nor does the University. Investigators must submit their studies to the IRB, which will make this determination. The IRB will NOT certify as exempt the following types of research at UCR:

More than minimal risk
Involves inpatients as subjects
Involves the intentional use of prisoners as subjects
Some uses of deception

Complete IRB Application Forms

For new submissions, please access UCR's Kuali Protocol Page.

To submit a protocol for IRB review, please access the IRB protocol form through the Kuali system and select “IRB Human Subjects Review” as the submission type. Submission of the protocol occurs directly within the system.

For information regarding available training opportunities, please see below resources.

Kuali IRB Resources

Common mistakes that may delay your review and approval include not providing enough information pertaining to your study or not submitting all relevant documents requested/listed in the protocol form. This includes all assessments or information given to participants. Please see Reasons for IRB Delays below.

Timelines

The IRB utilizes an initial pre-review screening process whereby each application is reviewed for completeness and compliance. During this process, researchers may be asked to make changes to their submissions before being reviewed by the IRB (pre-review). Once the researchers address pre-review comments, the IRB then reviews the revised application. IRB reviewer(s) may also ask for changes or clarifications, which they will communicate to the research team after IRB review (post-review).

Reasons for IRB Delays
Top Reasons for Delay
Not following the instructions in the protocol

Not providing required attachments (e.g., informed consent form, survey instruments, questionnaires, etc.)

Including inconsistent information between the IRB protocol and the consent form

Not providing consistent information on the handling and storage of sensitive and/or identifiable data

Not providing sufficient detail on how the informed consent process will take place

Not providing information that is requested after review

Failing to provide letters of permission (access letters) from external sites involved in the research

Not completing the Human Subjects Protection Course for all those involved in the research

Incomplete Ancillary Review by Department Chair or designee

Submitting the protocol before contacting the IRB office to discuss research ethics issues

For more information, contact irbsupport@ucr.edu.

IRB Process Flowchart

As detailed above in "Review Levels", there are three types of IRB review, as determined by the ORC. Depending on the level of review, the following timelines can apply. These review times are averages. Depending on the complexity of protocols and the workload in the office, additional time may be necessary to conduct appropriate reviews. Please note, these review times do not include the time the protocol is with the research team for revisions or time spent for ancillary reviews (i.e., required reviews by other offices such as ITS, FERPA, SOM Compliance, etc.).


Full Board	For Full Board review, IRB comments will be forwarded to you within two weeks following the regularly-scheduled monthly meeting. Please see below the schedule of IRB meetings & submission deadlines.
Expedited Exempt	Submissions for Minimal Risk studies are currently taking approximately 8-9 weeks to be processed and reviewed. Rolling submissions ARE accepted. You must still submit an IRB protocol for review to receive an “Exempt” determination.

Full Board

For Full Board review, IRB comments will be forwarded to you within two weeks following the regularly-scheduled monthly meeting. Please see below the schedule of IRB meetings & submission deadlines.

Expedited

Exempt

Submissions for Minimal Risk studies are currently taking approximately 8-9 weeks to be processed and reviewed. Rolling submissions ARE accepted.
You must still submit an IRB protocol for review to receive an “Exempt” determination.

Schedule of IRB Meetings & Submission Deadlines for Full Board Reviews

*May be subject to change

For other application types that the ORI has determined full board review is not required (i.e., minimal risk), the duration of the review and approval process will vary based on your study and may take several weeks. Applications should be submitted well ahead of any research to be conducted.

Important points to keep in mind

The IRB normally meets on the 3rd Monday of each month. In order for an application to be placed on the agenda for a meeting, researchers should plan to submit their applications well in advance of the anticipated study start and adequately address any issues raised during the pre-review process.
Depending on the complexity and risk levels associated with the study, Research Compliance will categorize the application submission for review. Applications will be reviewed on a first-come, first-served basis which also includes study amendment applications and continuing renewals. Therefore, the ORI highly recommends accurate and timely submission of the application and attachments to account for this review process.
Investigators may receive requests from the ORI to make changes to your submission during the pre-review screening process and/or after formal IRB Member/Board review. These comments must be addressed prior to IRB approval and a deadline for response will be provided. Once satisfactory responses are received, the ORI will move the application to the next step in the review process.

Complete Education & Training

Required Human Subjects Protection Training - All investigators and staff conducting human subjects research are required to complete the Collaborative Institutional Training Initiative (CITI) online courses. Researchers should select the courses that specifically pertain to their field or involvement in the human subjects research project. Options include:
- Social & behavioral research investigators
- Biomedical Research Investigators
- Research with data or laboratory specimens ONLY
IRB approval cannot be issued until the Lead Researcher and faculty advisor/supervisor (if applicable) have completed the required ethics training
The Lead Researcher is responsible for ensuring the completion of Human Subjects Protection Training for all research personnel (including staff and students) involved in the research.

Additional Information

Researchers and committee members can find more information in the IRB section of the Resources page.

IRB Consults & Contact Information

University of California, Riverside
Office of Research Integrity
Phone: 951-827-4802
IRB@ucr.edu

ORI offers IRB consultations for UCR investigators and research staff who are preparing IRB submissions (new studies, amendments) or preparing responses to review comments. Please email us at IRB@ucr.edu to set up an appointment to speak with an ORI representative.